Registered entities
Onconic Therapeutics Co., Ltd.
Reg. No. 268-86-01778South Korea
Innovation
14 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 104 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 9 |
| 2025 | 11 |
| 2026 | 8 |
Investor mix
11 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 36% |
| Private equity | 2 | 18% |
| Other / undisclosed | 5 | 45% |